<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-16T04:01:56Z</responseDate><request verb="GetRecord" identifier="oai:gredos.usal.es:10366/169706" metadataPrefix="dim">https://gredos.usal.es/oai/request</request><GetRecord><record><header><identifier>oai:gredos.usal.es:10366/169706</identifier><datestamp>2026-02-11T01:01:38Z</datestamp><setSpec>com_10366_3992</setSpec><setSpec>com_10366_3947</setSpec><setSpec>com_10366_3946</setSpec><setSpec>com_10366_3823</setSpec><setSpec>col_10366_3993</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="9ec65f28-b0db-414d-95c9-63c146b538a7" confidence="500" orcid_id="">Rovira-Llopis, Susana</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="58633f3e-3a03-4a45-ba1b-ac89169b3963" confidence="500" orcid_id="">Bañuls, Celia</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="8065e319-8c73-4cd5-a42f-42d6915c87d5" confidence="500" orcid_id="">de Marañon, Aranzazu M.</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="3445" confidence="600" orcid_id="">Díaz Morales, Noelia</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="afa2e6c1-f065-4f9a-9bb5-fb144e26da06" confidence="500" orcid_id="">Jover, Ana</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="f4dd8a54-26b6-4d38-8ccf-bf241a988791" confidence="500" orcid_id="">Garzon, Sandra</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="2973564b-46e8-4c6d-9488-b402e3052e7e" confidence="500" orcid_id="">Rocha, Milagros</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="ae878cb8-3328-418b-bf6f-55242c8064e0" confidence="500" orcid_id="">Victor, Victor M.</dim:field>
<dim:field mdschema="dc" element="contributor" qualifier="author" authority="9a3c2c80-c9af-4eaa-aaca-3ee2b900de7c" confidence="500" orcid_id="">Hernandez-Mijares, Antonio</dim:field>
<dim:field mdschema="dc" element="date" qualifier="accessioned">2026-02-10T12:28:18Z</dim:field>
<dim:field mdschema="dc" element="date" qualifier="available">2026-02-10T12:28:18Z</dim:field>
<dim:field mdschema="dc" element="date" qualifier="issued">2017</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="citation" lang="es_ES">Rovira-Llopis, S., Bañuls, C., de Marañon, A. M., Diaz-Morales, N., Jover, A., Garzon, S., Rocha, M., Victor, V. M., &amp; Hernandez-Mijares, A. (2017). Low testosterone levels are related to oxidative stress, mitochondrial dysfunction and altered subclinical atherosclerotic markers in type 2 diabetic male patients. Free radical biology &amp; medicine, 108, 155–162. https://doi.org/10.1016/j.freeradbiomed.2017.03.029</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="issn">0891-5849</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/10366/169706</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="doi">10.1016/j.freeradbiomed.2017.03.029</dim:field>
<dim:field mdschema="dc" element="identifier" qualifier="pmid">28359952</dim:field>
<dim:field mdschema="dc" element="description" qualifier="abstract" lang="es_ES">[EN]Introduction: Low testosterone levels in men are associated with type 2 diabetes and cardiovascular risk. However, the role of testosterone in mitochondrial function and leukocyte-endothelium interactions is unknown. Our aim was to evaluate the relationship between testosterone levels, metabolic parameters, oxidative stress, mitochondrial function, inflammation and leukocyte-endothelium interactions in type 2 diabetic patients.&#xd;
&#xd;
Materials and methods: The study was performed in 280 male type 2 diabetic patients and 50 control subjects. Anthropometric and metabolic parameters, testosterone levels, reactive oxygen species (ROS) production, mitochondrial membrane potential, TNFα, adhesion molecules and leukocyte-endothelium cell interactions were evaluated.&#xd;
&#xd;
Results: Testosterone levels were lower in diabetic patients. Total and mitochondrial ROS were increased and mitochondrial membrane potential, SOD and GSR expression levels were reduced in diabetic patients. TNFα, ICAM-1 and VCAM-1 levels, leukocyte rolling flux and adhesion were all enhanced in diabetic patients, while rolling velocity was reduced. Testosterone levels correlated negatively with glucose, HOMA-IR, HbA1c, triglycerides, nonHDL-c, ApoB, hs-CRP and AIP, and positively with HDL-c and ApoA1. The multivariable regression model showed that HDL-c, HOMA-IR and age were independently associated with testosterone. Furthermore, testosterone levels correlated positively with membrane potential and rolling velocity and negatively with ROS production, VCAM-1, rolling flux and adhesion.&#xd;
&#xd;
Conclusions: Our data highlight that low testosterone levels in diabetic men are related to impaired metabolic profile and mitochondrial function and enhanced inflammation and leukocyte-endothelium cell interaction, which leaves said patients at risk of cardiovascular events.</dim:field>
<dim:field mdschema="dc" element="description" qualifier="sponsorship" lang="es_ES">Fondo Europeo de Desarrollo Regional (FEDER), Instituto de Salud Carlos III (ISCIII), Ministerio de Economía y Competitividad, Generalitat Valenciana (Ministry of Education of the Valencian Regional Government), Fundación FISABIO</dim:field>
<dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
<dim:field mdschema="dc" element="language" qualifier="iso" lang="es_ES">eng</dim:field>
<dim:field mdschema="dc" element="publisher" lang="es_ES">Elsevier Inc.</dim:field>
<dim:field mdschema="dc" element="rights" lang="*">Attribution-NonCommercial-NoDerivatives 4.0 Internacional</dim:field>
<dim:field mdschema="dc" element="rights" qualifier="uri" lang="*">http://creativecommons.org/licenses/by-nc-nd/4.0/</dim:field>
<dim:field mdschema="dc" element="rights" qualifier="accessRights" lang="es_ES">info:eu-repo/semantics/openAccess</dim:field>
<dim:field mdschema="dc" element="subject" lang="es_ES">Testosterona</dim:field>
<dim:field mdschema="dc" element="subject" lang="es_ES">Diabetes tipo 2</dim:field>
<dim:field mdschema="dc" element="subject" lang="es_ES">Riesgo cardiovascular</dim:field>
<dim:field mdschema="dc" element="subject" lang="es_ES">Mitocondria</dim:field>
<dim:field mdschema="dc" element="subject" lang="es_ES">Leucocitos</dim:field>
<dim:field mdschema="dc" element="subject" lang="es_ES">Estrés oxidativo</dim:field>
<dim:field mdschema="dc" element="subject" lang="es_ES">Disfunción mitocondrial</dim:field>
<dim:field mdschema="dc" element="subject" lang="es_ES">Testosterone</dim:field>
<dim:field mdschema="dc" element="subject" lang="es_ES">Type 2 diabetes</dim:field>
<dim:field mdschema="dc" element="subject" lang="es_ES">Cardiovascular risk</dim:field>
<dim:field mdschema="dc" element="subject" lang="es_ES">Mitochondria</dim:field>
<dim:field mdschema="dc" element="subject" lang="es_ES">Leukocytes</dim:field>
<dim:field mdschema="dc" element="subject" lang="es_ES">Oxidative stress</dim:field>
<dim:field mdschema="dc" element="subject" lang="es_ES">Mitochondrial dysfunction</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="mesh" lang="*" authority="D003924" confidence="500">Diabetes Mellitus, Type 2</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="mesh" lang="*" authority="D002318" confidence="500">Cardiovascular Diseases</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="mesh" lang="*" authority="D018384" confidence="500">Oxidative Stress</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="mesh" lang="*" authority="D008928" confidence="500">Mitochondria</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="mesh" lang="*" authority="D013739" confidence="500">Testosterone</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="mesh" lang="*" authority="D012307" confidence="500">Risk Factors</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="mesh" lang="*" authority="D007962" confidence="500">Leukocytes</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="unesco" lang="es_ES">3209 Farmacología</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="unesco" lang="es_ES">2410.10 Fisiología Humana</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="unesco" lang="es_ES">3205.02 Endocrinología</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="unesco" lang="es_ES">2403 Bioquímica</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="unesco" lang="es_ES">3207.04 Patología Cardiovascular</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="decs" lang="*" authority="3946" confidence="500">diabetes mellitus tipo II</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="decs" lang="*" authority="2359" confidence="500" orcid_id="0000-0003-1341-8767">enfermedades cardiovasculares</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="decs" lang="*" authority="9117" confidence="500">mitocondrias</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="decs" lang="*" authority="32101" confidence="500">estrés oxidativo</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="decs" lang="*" authority="28612" confidence="500">factores de riesgo</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="decs" lang="*" authority="14118" confidence="500">testosterona</dim:field>
<dim:field mdschema="dc" element="subject" qualifier="decs" lang="*" authority="8140" confidence="500">leucocitos</dim:field>
<dim:field mdschema="dc" element="title" lang="es_ES">Low testosterone levels are related to oxidative stress, mitochondrial dysfunction and altered subclinical atherosclerotic markers in type 2 diabetic male patients</dim:field>
<dim:field mdschema="dc" element="type" lang="es_ES">info:eu-repo/semantics/article</dim:field>
<dim:field mdschema="dc" element="type" qualifier="hasVersion" lang="es_ES">info:eu-repo/semantics/acceptedVersion</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="publishversion" lang="es_ES">https://doi.org/10.1016/j.freeradbiomed.2017.03.029</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="projectID" lang="es_ES">PI15/1424</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="projectID" lang="es_ES">PI16/1083</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="projectID" lang="es_ES">PI16/00301</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="projectID" lang="es_ES">CB06/04/0071</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="projectID" lang="es_ES">PROMETEO 2014/035</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="projectID" lang="es_ES">GV/2016/169</dim:field>
<dim:field mdschema="dc" element="relation" qualifier="projectID" lang="es_ES">UGP15-193</dim:field>
<dim:field mdschema="dc" element="journal" qualifier="title" lang="es_ES">Free Radical Biology and Medicine</dim:field>
<dim:field mdschema="dc" element="volume" qualifier="number" lang="es_ES">108</dim:field>
<dim:field mdschema="dc" element="page" qualifier="initial" lang="es_ES">155</dim:field>
<dim:field mdschema="dc" element="page" qualifier="final" lang="es_ES">162</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>